Astrana Health, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
Astrana Health, Inc. (ASTH) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of -$8.09 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2026-08-10
- Astrana Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2026-06-30 was -$8.67M, a 546.14% decline year-over-year.
- Astrana Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2026-03-31 was $580.00K, a 59.78% decline year-over-year.
- Astrana Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-12-31 was $813.00K.
- Astrana Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-09-30 was $477.00K, a 68.18% decline year-over-year.
- Astrana Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2025 was $4.68M, a 51.18% increase from fiscal 2024.
- Astrana Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2024 was $3.09M, a 96.13% increase from fiscal 2023.
- Astrana Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2023 was $1.58M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$8.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$8.09M 10-Q · filed 2026-08-10 | -$7.28M derived: sum of 3 quarters · filed 2026-08-10 | -$6.80M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $580.00K 10-Q · filed 2026-05-08 | $1.39M derived: sum of 2 quarters · filed 2026-05-08 | $1.87M derived: sum of 3 quarters · filed 2026-05-08 | $3.81M derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-12-31 | $813.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.29M derived: sum of 2 quarters · filed 2026-03-12 | $3.23M derived: sum of 3 quarters · filed 2026-03-12 | $4.68M 10-K · filed 2026-03-12 |
| 2025-09-30 | $477.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $2.42M derived: sum of 2 quarters · filed 2025-11-10 | $3.86M 10-Q · filed 2025-11-10 | $3.31M derived: sum of 4 quarters · filed 2025-11-10 |
| 2025-06-30 | $1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $3.39M 10-Q · filed 2025-08-07 | $2.84M derived: sum of 3 quarters · filed 2025-08-07 | $4.33M derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | $1.44M 10-Q · filed 2025-05-09 | $892.00K derived: sum of 2 quarters · filed 2025-05-09 | $2.39M derived: sum of 3 quarters · filed 2025-05-09 | $2.62M derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-12-31 | -$550.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $949.00K derived: sum of 2 quarters · filed 2025-03-14 | $1.18M derived: sum of 3 quarters · filed 2025-03-14 | $3.09M 10-K · filed 2025-03-14 |
| 2024-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.73M derived: sum of 2 quarters · filed 2024-11-12 | $3.64M 10-Q · filed 2024-11-12 | $3.56M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | $233.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $2.14M 10-Q · filed 2024-08-09 | $2.06M derived: sum of 3 quarters · filed 2024-08-09 | $2.73M derived: sum of 4 quarters · filed 2024-08-09 |
| 2024-03-31 | $1.91M 10-Q · filed 2024-05-09 | $1.83M derived: sum of 2 quarters · filed 2024-05-09 | $2.50M derived: sum of 3 quarters · filed 2024-05-09 | |
| 2023-12-31 | -$79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $590.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.58M 10-K · filed 2024-02-29 | |
| 2023-09-30 | $669.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.66M 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | $987.00K 10-Q · filed 2023-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ICF International, Inc. (ICFI) | United States | $1.490B | 14.74 |
| Huron Consulting Group Inc. (HURN) | United States | $2.557B | 20.80 |
| EXPONENT INC (EXPO) | United States | $3.065B | 26.46 |
| Bowman Consulting Group Ltd. (BWMN) | United States | $0.738B | 68.09 |
| Onterris, Inc. (ONT) | United States | $0.590B | -63.69 |
| Public Policy Holding Company, Inc. (PPHC) | United States | $0.347B | |
| Aeries Technology, Inc. (AERT) | Cayman Islands | $0.336B | -0.00 |
| TSS, Inc. (TSSI) | United States | $0.288B | 24.06 |
| Information Services Group Inc. (III) | United States | $0.256B | 16.97 |
| HACKETT GROUP, INC. (HCKT) | United States | $0.254B |